Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Wei-Jie Guan and Nanshan Zhong.
Wei-Jie Guan
Connection Strength
17.895
Nanshan Zhong
  1. Chronic Respiratory Diseases and the Outcomes of COVID-19: A Nationwide Retrospective Cohort Study of 39,420 Cases. J Allergy Clin Immunol Pract. 2021 07; 9(7):2645-2655.e14.
    View in: PubMed
    Score: 0.933
  2. Erratum to hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial. J Thorac Dis. 2020 Aug; 12(8):4591-4592.
    View in: PubMed
    Score: 0.895
  3. Cardiovascular comorbidity and its impact on patients with COVID-19. Eur Respir J. 2020 06; 55(6).
    View in: PubMed
    Score: 0.887
  4. Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial. J Thorac Dis. 2020 Jun; 12(6):3448-3452.
    View in: PubMed
    Score: 0.885
  5. Strategies for the prevention and management of coronavirus disease 2019. Eur Respir J. 2020 04; 55(4).
    View in: PubMed
    Score: 0.877
  6. Letter from China. Respirology. 2020 06; 25(6):657-658.
    View in: PubMed
    Score: 0.876
  7. Clinical Characteristics of Covid-19 in China. Reply. N Engl J Med. 2020 05 07; 382(19):1861-1862.
    View in: PubMed
    Score: 0.874
  8. Health Perception and Behaviors in Adults With Bronchiectasis. Respir Care. 2019 Apr; 64(4):462-472.
    View in: PubMed
    Score: 0.799
  9. Sputum purulence-associated microbial community compositions in adults with bronchiectasis. J Thorac Dis. 2018 Sep; 10(9):5508-5514.
    View in: PubMed
    Score: 0.784
  10. Altered community compositions of Proteobacteria in adults with bronchiectasis. Int J Chron Obstruct Pulmon Dis. 2018; 13:2173-2182.
    View in: PubMed
    Score: 0.777
  11. Next-generation sequencing for identifying genetic mutations in adults with bronchiectasis. J Thorac Dis. 2018 May; 10(5):2618-2630.
    View in: PubMed
    Score: 0.766
  12. Effects of para-toluenesulfonamide intratumoral injection on pulmonary adenoid cystic carcinoma complicating with severe central airway obstruction: a 5-year follow-up study. J Thorac Dis. 2018 Apr; 10(4):2448-2455.
    View in: PubMed
    Score: 0.761
  13. Macrolides, mucoactive drugs and adherence for the management of bronchiectasis. Eur Respir J. 2018 01; 51(1).
    View in: PubMed
    Score: 0.749
  14. Residual volume/total lung capacity ratio confers limited additive significance to lung clearance index for assessment of adults with bronchiectasis. PLoS One. 2017; 12(9):e0183779.
    View in: PubMed
    Score: 0.732
  15. Industrial pollutant emission and the major smog in China: from debates to action. Lancet Planet Health. 2017 05; 1(2):e57.
    View in: PubMed
    Score: 0.715
  16. Additional important research priorities for bronchiectasis in China. Eur Respir J. 2017 01; 49(1).
    View in: PubMed
    Score: 0.701
  17. Effect of airway Pseudomonas aeruginosa isolation and infection on steady-state bronchiectasis in Guangzhou, China. J Thorac Dis. 2015 Apr; 7(4):625-36.
    View in: PubMed
    Score: 0.618
  18. Six-minute walk test in Chinese adults with clinically stable bronchiectasis: association with clinical indices and determinants. Curr Med Res Opin. 2015 Apr; 31(4):843-52.
    View in: PubMed
    Score: 0.615
  19. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study. Emerg Microbes Infect. 2021 Dec; 10(1):1751-1759.
    View in: PubMed
    Score: 0.245
  20. The benefits of pulmonary rehabilitation in patients with COVID-19. ERJ Open Res. 2021 Apr; 7(2).
    View in: PubMed
    Score: 0.237
  21. Impact of Chronic Respiratory Diseases on the Outcomes of COVID-19. Arch Bronconeumol. 2022 Jan; 58(1):5-7.
    View in: PubMed
    Score: 0.237
  22. Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial. JAMA Intern Med. 2021 01 01; 181(1):71-78.
    View in: PubMed
    Score: 0.230
  23. Clinical characteristics of COVID-19 in developing countries of western pacific: Low case-fatality rate unraveled. Lancet Reg Health West Pac. 2021 Jan; 6:100073.
    View in: PubMed
    Score: 0.229
  24. Strategies and Advances in Combating COVID-19 in China. Engineering (Beijing). 2020 Oct; 6(10):1076-1084.
    View in: PubMed
    Score: 0.227
  25. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial. Phytomedicine. 2021 May; 85:153242.
    View in: PubMed
    Score: 0.221
  26. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020 05; 55(5).
    View in: PubMed
    Score: 0.220
  27. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 04 30; 382(18):1708-1720.
    View in: PubMed
    Score: 0.217
  28. Evaluation of the Normal Airway Morphology Using Optical Coherence Tomography. Chest. 2019 11; 156(5):915-925.
    View in: PubMed
    Score: 0.207
  29. Significances of spirometry and impulse oscillometry for detecting small airway disorders assessed with endobronchial optical coherence tomography in COPD. Int J Chron Obstruct Pulmon Dis. 2018; 13:3031-3044.
    View in: PubMed
    Score: 0.197
  30. Incidence and risk of thromboembolism associated with bevacizumab in patients with non-small cell lung carcinoma. J Thorac Dis. 2018 Aug; 10(8):5010-5022.
    View in: PubMed
    Score: 0.195
  31. Motile Ciliary Disorders in Chronic Airway Inflammatory Diseases: Critical Target for Interventions. Curr Allergy Asthma Rep. 2018 07 26; 18(9):48.
    View in: PubMed
    Score: 0.195
  32. Increased intracellular Cl- concentration promotes ongoing inflammation in airway epithelium. Mucosal Immunol. 2018 07; 11(4):1149-1157.
    View in: PubMed
    Score: 0.190
  33. Inhaled medication therapy for bronchiectasis: status quo and the next frontier. Expert Opin Investig Drugs. 2018 03; 27(3):211-218.
    View in: PubMed
    Score: 0.189
  34. A Critical Review of the Quality of Cough Clinical Practice Guidelines. Chest. 2016 Oct; 150(4):777-788.
    View in: PubMed
    Score: 0.167
  35. Earlier diagnosis improves COVID-19 prognosis: a nationwide retrospective cohort analysis. Ann Transl Med. 2021 Jun; 9(11):941.
    View in: PubMed
    Score: 0.059
  36. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China. Eur Respir J. 2020 06; 55(6).
    View in: PubMed
    Score: 0.055
  37. Case report: dermatomyositis associated with lung cancer with heterogeneous morphology. J Thorac Dis. 2017 Dec; 9(12):E1110-E1117.
    View in: PubMed
    Score: 0.047
  38. Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease. N Engl J Med. 2017 09 07; 377(10):923-935.
    View in: PubMed
    Score: 0.046
  39. The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: a prospective study. Chest. 2015 Jun; 147(6):1635-1643.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.